Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning

Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning

Early this year, a medical journal article caught the attention of cancer patients and doctors worldwide because of its extraordinary conclusion. Simply changing the time of day that immunotherapy was administered appeared to produce a stunning benefit for lung cancer patients. Those who received IV infusions in the morning had their cancer kept at bay…

Read Full News
Shortage of Chemotherapy Drugs Brings Rationing Fears for Cancer Patients

Shortage of Chemotherapy Drugs Brings Rationing Fears for Cancer Patients

Doctors treating cancer patients nationwide are facing a shortage of essential generic chemotherapy drugs, a situation that many fear could lead to widespread rationing. The shortages stem from manufacturing problems, shipping delays and decisions by some companies to stop producing the medications, according to the Food and Drug Administration. The decades-old medicines are challenging to…

Read Full News
Cancer patients found a simple way to stay mentally sharp during chemotherapy

Cancer patients found a simple way to stay mentally sharp during chemotherapy

Many people undergoing chemotherapy experience a frustrating side effect often called “chemo brain.” These cognitive changes can include trouble concentrating, memory problems, and difficulty juggling multiple tasks. According to researchers, as many as 80% of chemotherapy patients experience some degree of cancer-related cognitive impairment. Now, a Phase II clinical trial suggests that two relatively simple…

Read Full News
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 women found that those taking GLP-1 drugs, a category that includes semaglutide-based medications like Ozempic and Wegovy, were significantly less likely to develop breast cancer. The findings…

Read Full News